Literature DB >> 19239257

Stereocontrolled approach to phenyl cyclitols from (SR)-[(p-tolylsulfinyl)methyl]-p-quinol.

Estíbaliz Merino1, Rosanne P A Melo, Montserrat Ortega-Guerra, María Ribagorda, M Carmen Carreño.   

Abstract

Reactions of enantiopure (SR)-[(p-tolylsulfinyl)methyl]-p-quinol with ArAlMe(2) reagents allowed a highly diastereoselective 1,4-addition of the aryl group with an efficient desymmetrization of the prochiral cyclohexadienone moiety. The asymmetric synthesis of phenyl-substituted polyoxygenated cyclohexane derivatives was achieved by combining this reaction with a stereoselective reduction and elimination of the beta-hydroxysulfoxide, after oxidation to sulfone, to recover a carbonyl group, and a stereoselective epoxidation.

Entities:  

Year:  2009        PMID: 19239257     DOI: 10.1021/jo900109p

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  4 in total

Review 1.  Enantioselective and Enantiospecific Transition-Metal-Catalyzed Cross-Coupling Reactions of Organometallic Reagents To Construct C-C Bonds.

Authors:  Alan H Cherney; Nathaniel T Kadunce; Sarah E Reisman
Journal:  Chem Rev       Date:  2015-08-13       Impact factor: 60.622

2.  Asymmetric transformations of achiral 2,5-cyclohexadienones.

Authors:  Kyle A Kalstabakken; Andrew M Harned
Journal:  Tetrahedron       Date:  2014-12-23       Impact factor: 2.457

3.  Quaternary carbon stereogenic centers through copper-catalyzed enantioselective allylic substitutions with readily accessible aryl- or heteroaryllithium reagents and aluminum chlorides.

Authors:  Fang Gao; Yunmi Lee; Kyoko Mandai; Amir H Hoveyda
Journal:  Angew Chem Int Ed Engl       Date:  2010-11-02       Impact factor: 15.336

4.  Synthesis of Substituted Benzaldehydes via a Two-Step, One-Pot Reduction/Cross-Coupling Procedure.

Authors:  Dorus Heijnen; Hugo Helbert; Gert Luurtsema; Philip H Elsinga; Ben L Feringa
Journal:  Org Lett       Date:  2019-05-14       Impact factor: 6.005

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.